129 related articles for article (PubMed ID: 37300942)
21. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U
ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Biodistribution of Engineered Lipid Microbubbles in Rodents.
Oddo L; Paradossi G; Cerroni B; Ben-Harush C; Ariel E; Di Meco F; Ram Z; Grossman R
ACS Omega; 2019 Aug; 4(8):13371-13381. PubMed ID: 31460465
[TBL] [Abstract][Full Text] [Related]
23. Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents.
Sanna V; Pintus G; Bandiera P; Anedda R; Punzoni S; Sanna B; Migaleddu V; Uzzau S; Sechi M
Mol Pharm; 2011 Jun; 8(3):748-57. PubMed ID: 21545176
[TBL] [Abstract][Full Text] [Related]
24. NIR-II fluorescence visualization of ultrasound-induced blood-brain barrier opening for enhanced photothermal therapy against glioblastoma using indocyanine green microbubbles.
Liang S; Hu D; Li G; Gao D; Li F; Zheng H; Pan M; Sheng Z
Sci Bull (Beijing); 2022 Nov; 67(22):2316-2326. PubMed ID: 36546222
[TBL] [Abstract][Full Text] [Related]
25. Accurately Controlled Delivery of Temozolomide by Biocompatible UiO-66-NH
Wan Z; Li C; Gu J; Qian J; Zhu J; Wang J; Li Y; Jiang J; Chen H; Luo C
Int J Nanomedicine; 2021; 16():6905-6922. PubMed ID: 34675514
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound/Magnetic Targeting with SPIO-DOX-Microbubble Complex for Image-Guided Drug Delivery in Brain Tumors.
Fan CH; Cheng YH; Ting CY; Ho YJ; Hsu PH; Liu HL; Yeh CK
Theranostics; 2016; 6(10):1542-56. PubMed ID: 27446489
[TBL] [Abstract][Full Text] [Related]
27. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.
Zhao Z; Shen J; Zhang L; Wang L; Xu H; Han Y; Jia J; Lu Y; Yu R; Liu H
Biomater Sci; 2020 Sep; 8(19):5306-5316. PubMed ID: 32573615
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment.
Fan CH; Ting CY; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2013 Mar; 34(8):2142-55. PubMed ID: 23246066
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO
Uribe-Robles M; Ortiz-Islas E; Rodriguez-Perez E; Valverde FF; Lim T; Martinez-Morales AA
Biomater Adv; 2023 Aug; 151():213442. PubMed ID: 37207587
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence labeled microbubbles for multimodal imaging.
Barrefelt Å; Zhao Y; Larsson MK; Egri G; Kuiper RV; Hamm J; Saghafian M; Caidahl K; Brismar TB; Aspelin P; Heuchel R; Muhammed M; Dähne L; Hassan M
Biochem Biophys Res Commun; 2015 Aug; 464(3):737-42. PubMed ID: 26187672
[TBL] [Abstract][Full Text] [Related]
33. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
34. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
35. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
36. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
37. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
38. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
39. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
Weller GE; Wong MK; Modzelewski RA; Lu E; Klibanov AL; Wagner WR; Villanueva FS
Cancer Res; 2005 Jan; 65(2):533-9. PubMed ID: 15695396
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
